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ABSTRACT
Rationale Genome- wide association studies (GWASs) 
have identified numerous loci associated with lower 
pulmonary function. Pulmonary function is strongly related 
to smoking and has also been associated with asthma 
and dust endotoxin. At the individual SNP level, genome- 
wide analyses of pulmonary function have not identified 
appreciable evidence for gene by environment interactions. 
Genetic Risk Scores (GRSs) may enhance power to identify 
gene–environment interactions, but studies are few.
Methods We analysed 2844 individuals of European 
ancestry with 1000 Genomes imputed GWAS data from 
a case–control study of adult asthma nested within a US 
agricultural cohort. Pulmonary function traits were FEV1, FVC 
and FEV1/FVC. Using data from a recent large meta- analysis 
of GWAS, we constructed a weighted GRS for each trait 
by combining the top (p value<5×10−9) genetic variants, 
after clumping based on distance (±250 kb) and linkage 
disequilibrium (r2=0.5). We used linear regression, adjusting 
for relevant covariates, to estimate associations of each trait 
with its GRS and to assess interactions.
Results Each trait was highly significantly associated 
with its GRS (all three p values<8.9×10−8). The inverse 
association of the GRS with FEV1/FVC was stronger for 
current smokers (pinteraction=0.017) or former smokers 
(pinteraction=0.064) when compared with never smokers 
and among asthmatics compared with non- asthmatics 
(pinteraction=0.053). No significant interactions were observed 
between any GRS and house dust endotoxin.
Conclusions Evaluation of interactions using GRSs 
supports a greater impact of increased genetic susceptibility 
on reduced pulmonary function in the presence of smoking 
or asthma.
INTRODUCTION
Spirometric measures of pulmonary function, such 
as FEV1, FVC and their ratio, FEV1/FVC, are robust 
indices of respiratory health used in diagnosing 
and monitoring various lung conditions, including 
COPD. These pulmonary function metrics are 
predictors of mortality, even after adjusting for 
known risk factors.1–4
Pulmonary function is influenced by both genetic 
and environmental factors. Genome- wide associa-
tion studies (GWASs) have identified many loci asso-
ciated with pulmonary function.5–9 Environmental 
exposures, most notably, cigarette smoking, also 
substantially influence pulmonary function.10 11 
Endotoxin, a lipopolysaccharide on the cell wall 
of Gram- negative bacteria ubiquitous in the envi-
ronment, is a powerful initiator of innate immune 
response.12 Occupational endotoxin exposure is 
associated with lower lung function.13 14 Although 
endotoxin exposure in childhood might protect 
against asthma development,15 in adulthood, endo-
toxin in house dust has been associated with lower 
Key messages
What is the key question?
 ► Whether the reduction in pulmonary function 
associated with increasing genetic susceptibility 
is enhanced or reduced by having exposures to 
smoking or house dust endotoxin or by having 
asthma.
What is the bottom line?
 ► Smoking or asthma amplifies the reduction 
in FEV1/FVC that occurs with greater genetic 
susceptibility.
Why read on?
 ► Using the largest genome- wide association 
study meta- analysis of pulmonary function 
to date, we developed a robust Genetic Risk 
Score (GRS) for each pulmonary function 
trait in our data. We observed a significant 
interaction between the GRS for reduced FEV1/
FVC and smoking status. Our study is the 
first to examine interactions between GRSs 
for reduced pulmonary function and asthma 
status or house dust endotoxin exposure. We 
observed a marginally significant interaction 
between the GRS for reduced FEV1/FVC and 
asthma. The finding that the association of 
genetic susceptibility with reduced pulmonary 
function is strongest among current smokers 
and asthmatics provides evidence that the 
population with higher genetic risk for impaired 
pulmonary function is more susceptible to the 
deleterious effects of smoking and asthma.
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pulmonary function in asthmatics.16 17 Asthma is associated with 
reduced lung function in many studies.18
Considerable efforts to identify interactions between indi-
vidual genetic variants and environmental exposures for many 
human traits and diseases have identified few to no signifi-
cant interactions.19–21 Even with large sample sizes, power is 
limited to detect interactions with individual single- nucleotide 
polymorphisms (SNPs) in genome- wide analyses.19 Several 
authors have highlighted the advantage of using Genetic Risk 
Scores (GRSs) over individual SNPs for identifying significant 
interactions.22–24 For example, a genome- wide meta- analysis 
of FEV1 and FEV1/FVC by Hancock et al of nearly 50 000 
individuals incorporated interaction with smoking but identi-
fied no genome- wide significant interactions despite the well- 
established association of smoking with these phenotypes.20 
Using the summary results from Hancock et al20 for 26 SNPs 
previously identified in main effects GWAS of pulmonary func-
tion,7 Aschard et al performed single SNP- by- smoking inter-
action tests and found no significant interactions.24 However, 
combining the effects of these individual SNPs into a GRS 
identified a significant interaction between smoking status and 
the GRS on FEV1/FVC.
24 In a study of cotton textile workers, 
Zhang et al found a significant interaction between occupa-
tional endotoxin exposure and a 10- SNP GRS for lower FEV1 
for longitudinal decline in FEV1.
25 We are not aware of studies 
examining whether associations of GRSs with pulmonary func-
tion differ by asthma status.
Recently, a large- scale meta- analysis involving around 400 
000 participants of European ancestry from the UK Biobank and 
SpiroMeta consortium brought the number of loci for pulmo-
nary function to nearly 300.8 This largest meta- analysis of these 
outcomes to date, provides the ability to generate authoritative 
risk scores for pulmonary function in individuals of European 
ancestry. Shrine et al constructed a single GRS from variants 
identified for any of four pulmonary function traits (FEV1, FVC, 
FEV1/FVC and peak expiratory flow) weighted by the effect sizes 
for FEV1/FVC but found no interaction of GRS with ever- never 
smoking in relation to FEV1/FVC.
8
We constructed GRSs for reduced pulmonary function based 
on results from the aforementioned meta- analysis8 to investigate 
whether associated genetic risk for reduced pulmonary function 
is more pronounced in the presence of smoking or other expo-
sures related to reduced pulmonary function. We constructed a 
separate GRS for each of the three spirometric traits (FEV1, FVC 
and FEV1/FVC) based on the meta- analysis
8 and applied these 
three GRSs in a case–control study of asthma in adults nested 
within a US farming cohort with data on smoking and house 
dust endotoxin. We examined an interaction hypothesis, namely, 
whether the reduction in pulmonary function associated with 
increasing GRS is enhanced or reduced by exposure to smoking 
or house dust endotoxin or by having asthma.
METHODS
Study population and pulmonary function
The Agricultural Lung Health Study (ALHS) is a case–control 
study of current asthma in farmers and spouses of farmers, 
nested within the Agricultural Health Study.26 We enrolled 3301 
participants in the ALHS from 2009 to 2013. Details regarding 
the ALHS study design, including measurement of pulmonary 
function, have been previously reported.16 27 28 Briefly, pulmo-
nary function (FEV1 (in litres), FVC (in litres) and FEV1/FVC 
(proportion)) was measured during home visits by trained field 
technicians in accordance with American Thoracic Society 
guidelines.16 29 Tests were graded by Dr John Hankinson; partic-
ipants with quality grades of D or F were excluded from anal-
ysis.16 30
Classification of asthma
As previously described,16 27 asthma cases were identified from 
the larger Agricultural Health Study cohort in three categories: 
self- reported doctor- diagnosed current asthma, potential undiag-
nosed asthma based on the presence of current asthma symptoms 
and asthma medication use in non- smokers, and overlapping 
diagnoses of current asthma and either COPD or emphysema in 
non- smokers. A random sample of cohort members who did not 
meet any of these case definitions was selected for enrolment as 
non- cases.
Endotoxin measurements
House dust samples were collected by vacuuming bedroom 
floors and sleeping surfaces of participants.16 Endotoxin levels 
in house dust were measured using the Limulus amebocyte 
lysate assay (Lonza Walkersville, Walkersville, Maryland, USA), 
as previously described.31–33 Measurements below the limit of 
detection were assigned a value equal to that limit divided by the 
square root of two.
Assessment of smoking
Smoking history was obtained from questionnaires. Participants 
were classified as current, former or never smokers. Pack- years 
were calculated as packs smoked per day times years smoked.
Genotyping
Details about the genotyping, imputation and quality control are 
in the online supplemental material.
Genetic Risk Scores
Weighted GRSs were constructed using the complete summary 
results from the previous meta- analysis of more than 400 000 
individuals of European ancestry.8 The summary results were 
pruned for linkage disequilibrium (LD) using the p value informed 
clumping method in PLINK V.1.9,34 based on the LD structure in 
the ALHS using a distance of ±250 kb and LD threshold of 0.5. 
We used a p value threshold of 5×10―9 to maximise stringency 
and for consistency with currently recommended genome- wide 
significance thresholds for resequencing analyses of individuals 
of European ancestry.8 35 After LD clumping, the numbers of 
SNPs remaining for GRS calculation were 1123 for FEV1, 835 
for FVC and 1691 for FEV1/FVC. Weighted GRSs for ALHS 
participants were calculated as the weighted sum of the number 
of the risk alleles using effect estimates from the UK Biobank- 
SpiroMeta meta- analysis as weights.8 Further details about the 
calculation of GRSs can be found in the online supplemental 
material.
Statistical analyses
Using linear regression, we tested associations between each trait 
(FEV1 (litres), FVC (litres) and FEV1/FVC (proportion)) and 
its corresponding GRS adjusting for age, age2, height, height2, 
asthma (case and non- case), smoking status (current, former 
or never), pack- years of smoking, state of residence (Iowa and 
North Carolina), gender, first 10 genetic principal compo-
nents and weight (kg, FVC only). Model examining associa-
tions of traits with smoking (two dummy variables for former 
or current smoking vs never) included the aforementioned 
covariates without pack- years or principal components. Models 
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for association of traits with asthma were additionally adjusted 
for smoking and pack- years. Endotoxin was log10- transformed 
and models for association with traits were further adjusted for 
season of collection of dust sample. Interactions between the 
GRS and each exposure (smoking, asthma or endotoxin) were 
tested by adding product terms to the aforementioned models 
and adjusting for the first 10 genetic principal components. 
Where we identified significant two- way interactions, we consid-
ered further three- way interaction terms with the remaining two 
exposures. We considered a nominal p value cut- off of 0.05 for 
statistical significance of our results. All analyses were performed 
in R.36 Analyses used data release AHSREL201304.00.
RESULTS
Study participants
Among the 3301 ALHS participants, 3069 had spirometry 
passing quality control and complete data on smoking, asthma 
and covariates, including 2844 of European ancestry based on 
principal components analysis. Among these 2844 participants, 
1041 were asthma cases. Current smoking was reported by 
4.3% and former smoking by 29.5% (table 1). About 52% were 
farmers; the rest were spouses of farmers. House dust endotoxin 
measurements were available for 2385 participants. Among 
these, 177 visits were to homes where a spouse had already been 
enrolled; spouses were removed, leaving 2208 participants for 
analyses of endotoxin.
Association between exposures and pulmonary function
As expected, smoking status was highly significantly associ-
ated with lower FEV1 and FEV1/FVC, with larger effect esti-
mates for current smoking than for former smoking relative 
to never smoking (table 2). For FVC, inverse associations were 
observed for both current and former smoking, though the 
association for former smoking did not reach statistical signif-
icance (table 2). Pack- years of smoking was inversely associated 
with all three pulmonary function traits: FEV1: β=―0.009 L/
pack- year, p value<2.0×10−16; FEV1/FVC: β=―0.002 L/pack- 
year, p value<2.0×10−16; and FVC: β=―0.005 L/pack- year, p 
value=4.4×10−12.
Asthma was highly statistically significantly associated with 
lower pulmonary function for all three traits (table 2). Log10- 
transformed house dust endotoxin was inversely related to all 
three traits but not statistically significantly (table 2).
Genetic Risk Scores
Summary statistics of the GRSs for the three pulmonary function 
traits are shown in table 3; distributions of the GRSs are shown 
in online supplemental figure E1. As expected, the GRSs were 
highly significantly associated with lower values for each pulmo-
nary function trait (table 3, all p values<8.9×10−8).
Interaction between GRSs and smoking status
We observed significant interactions between the GRS for FEV1/
FVC and smoking status. The interaction effect between GRS 
and smoking status shows the difference in the effects of GRS 
on FEV1/FVC between smokers (current or former) and never 
smokers. The inverse association between GRS and FEV1/FVC 
was greater for current smokers than never smokers (table 4); 
the estimated effect of GRS, per unit increase, on FEV1/FVC 
in never smokers was −0.003 and that for the current smokers 
was −0.012 with a difference of −0.009 (pinteraction=0.017). Even 
for former smokers, the inverse association between GRS and 
FEV1/FVC was higher compared with never smokers, where 
the estimated effect of GRS on FEV1/FVC in former smokers 
was −0.006 vs −0.003 in never smokers, with a difference of 
−0.003 (pnteraction=0.064). Figure 1 plots the association between 
the GRS and FEV1/FVC according to smoking status and shows 
that the harmful effects of smoking were larger among partic-
ipants with higher GRSs. No significant interactions with the 
GRS were seen with smoking for FEV1 or FVC (lowest pinterac-
tion=0.357, online supplemental table E1). We also tested for 
interactions between the GRS and pack- years of smoking in rela-
tion to each of the three traits but none were close to statistically 
significant (FEV1: βinteraction=0.0003, pinteraction=0.406; FVC: βinter-
action=0.0005, pinteraction=0.480; FEV1/FVC: βinteraction=−0.00002, 
pinteraction=0.674). However, among current smokers, we observed 
a significant interaction between the GRS and the number of 
Table 1 Characteristics of the 2844 participants
Characteristics n (%)
Gender
  Female 1398 (49.2)
  Male 1446 (50.8)
Enrolment status
  Farmer 1491 (52.4)
  Spouse 1353 (47.6)
State
  Iowa 2055 (72.3)
  North Carolina 789 (27.7)
Current asthma status
  Case 1041 (36.6)
  Non- case 1803 (63.4)
Smoking status
  Never 1884 (66.2)
  Former 839 (29.5)
  Current 121 (4.3)
Season of endotoxin measurement (n=2208)*
  Summer 628 (28.4)
  Spring 586 (26.5)
  Fall 492 (22.3)
  Winter 502 (22.7)
FEV1
  Median (25th–75th percentiles) (L) 2.5 (2.0–3.1)
FVC
  Median (25th–75th percentiles) (L) 3.4 (2.8–4.2)
FEV1/FVC
  Median (25th–75th percentiles), proportion 0.75 (0.69–0.79)
Age
  Median (25th–75th percentiles) (years) 62.8 (54.8–71.3)
Pack- years in ever smokers
  Median (25th–75th percentiles) 9 (1.5–26.9)
Number of cigarettes per day in current smokers
  Median (25th–75th percentiles) 10 (5–20)
Endotoxin in house dust (n=2208)
  Median (25th–75th percentiles) (EU/mg) 43.5 (20.1–73.5)
*House dust endotoxin data were available for 2208 participants after removing 
the 177 for whom a visit was also made to a spouse.
3Sikdar S, et al. Thorax 2021;0:1–8. doi:10.1136/thoraxjnl-2020-215624
















cigarettes smoked per day for FEV1/FVC (βinteraction=−0.0004, 
pinteraction=0.027).
Given that there is some genetic contribution to smoking 
behaviour and we identified an interaction between the GRS 
and smoking status in relation to FEV1/FVC, we tested whether 
its GRS was related to smoking and found no appreciable asso-
ciation (adjusting for age, age2, height, height2, asthma status, 
state, gender and genetic principal components): former 
smokers β=0.162, SE=0.096, p value=0.090; current smokers 
β=−0.139, SE=0.210, p value=0.508.
Interaction between GRSs and asthma
We observed a marginally significant interaction between the 
GRS and asthma in relation to FEV1/FVC with a stronger inverse 
association between the GRS and FEV1/FVC in asthmatics (esti-
mated effect of a unit increase in GRS on FEV1/FVC=−0.006) 
than non- asthmatics (−0.003) with a pinteraction=0.053 (table 5). 
From figure 2, asthma had a stronger negative effect on FEV1/
FVC among participants with higher GRSs. No appreciable 
interaction with asthma was seen for FEV1 or FVC (online 
supplemental table E2).
Given the interaction between asthma and the GRS in relation 
to FEV1/FVC, we evaluated the association between asthma and 
the GRS for this trait, adjusting for age, age2, height, height2, 
smoking status, pack- years, state, gender and genetic principal 
components. The GRS for FEV1/FVC was not significantly 
related to asthma (β=0.136, SE=0.087, p value=0.116).
Three-way interaction between smoking, asthma and GRSs
For FEV1/FVC, we examined whether the interaction effect 
between GRS and smoking status differed by asthma. In asth-
matics, FEV1/FVC had steeper inverse relationship with 
increased genetic risk in current smokers (when compared with 
never smokers) than in non- asthmatics, yielding a statistically 
significant three- way interaction (online supplemental table 
E3 and online supplemental figure E2). The interaction effect 
between GRS and former smoking (in comparison to never 
smokers) for FEV1/FVC was not significantly different between 
asthmatics and non- asthmatics (online supplemental table E3).
Three-way interaction between smoking, gender and GRSs
Additionally, we examined whether the interaction effect 
between GRS for FEV1/FVC and smoking status differed by 
gender. In women, FEV1/FVC had a steeper inverse relation-
ship with increasing genetic risk in current smokers compared 
with never smokers, whereas no such difference between current 
and never smokers was observed in men, yielding a significant 
three- way interaction effect between GRS, gender and current 
smoking (vs never smoking) (online supplemental table E4 and 
figure E3). The interaction effect between GRS and former 
smoking (in comparison to never smokers) was not significantly 
different by gender (online supplemental table E4).
Interaction between GRSs and endotoxin
We observed no significant interactions between the GRS and 
endotoxin for any of the traits (table 6 and online supplemental 
table E5). Because we had previously reported a stronger associ-
ation between endotoxin and FEV1/FVC in asthmatics than non- 
asthmatics,16 we evaluated a possible three- way interaction with 
asthma but found no evidence for one (pthree- way interaction=0.667, 
online supplemental table E6).
DISCUSSION
As expected, all three pulmonary function traits (FEV1, FVC 
and FEV1/FVC) were significantly lower among both current 
and former smokers compared with never smokers, and asth-
matics had lower pulmonary function than non- asthmatics. 
Table 2 Association between the exposures and pulmonary function traits
Exposures n
FEV1 (L) FVC (L) FEV1/FVC
β (SE) P value β (SE) P value β (SE) P value
Smoking
  Never 1884 Referent – Referent – Referent –
  Former 839 −0.108* (0.021) 4.2×10−7 −0.028* (0.024) 0.246 −0.023* (0.003) 4.2×10−11
  Current 121 −0.412* (0.047) <2.0×10−16 −0.280* (0.052) 9.1×10−8 −0.084* (0.008) <2.0×10−16
Asthma
  No 1803 Referent – Referent – Referent –
  Yes 1041 −0.297† (0.019) <2.0×10−16 −0.155† (0.022) 1.1×10−12 −0.048† (0.003) <2.0×10−16
Endotoxin in house dust
  log10endotoxin 2208 −0.017‡ (0.015) 0.254 −0.002‡ (0.017) 0.883 −0.004‡ (0.002) 0.131
*Estimates adjusted for age, age2, state, gender, height, height2 and asthma status (body weight for FVC only).
†Estimates adjusted for age, age2, state, gender, height, height2, smoking status and pack- years (body weight for FVC only).
‡Estimates adjusted for age, age2, state, gender, height, height2, asthma status, season of dust collection, smoking status, and pack- years (body weight for FVC only).
Table 3 Association between GRSs and pulmonary function traits
Outcome
GRS
GRS effect estimate* SE P valueRange Median (25th–75th percentiles) Mean
FEV1 (L) 17.5–29.5 21.5 (20.6–22.6) 21.8 −0.029 0.005 8.8×10
−8
FVC (L) 13.1–19.8 15.8 (15.2–16.5) 15.9 −0.082 0.010 5.7×10−15
FEV1/FVC 34.2–51.5 42.1 (40.9–43.6) 42.3 −0.004 0.001 1.0×10
−9
*Effect estimates provide the change in the trait (in litres for FEV1 and FVC, proportion with range 0–1 for FEV1/FVC) per one unit increase in the GRSs. Pulmonary function traits were regressed on 
the GRS for that trait, with adjustment for age, age2, state, gender, height, height2, asthma status, smoking status, pack- years, first 10 principal components, and for FVC only, body weight.
GRS, Genetic Risk Score.
4 Sikdar S, et al. Thorax 2021;0:1–8. doi:10.1136/thoraxjnl-2020-215624
















We developed a separate GRS for each of the three pulmonary 
function traits in our study population using a large- scale meta- 
analysis of European ancestry populations.8 These GRSs were 
highly statistically significantly associated with lower values for 
their corresponding pulmonary function traits. We observed a 
significant interaction effect where the reduction in FEV1/FVC 
with increasing GRS was more pronounced among current 
smokers and former than never smokers. We also found some 
evidence of interaction where the reduction in FEV1/FVC with 
increasing GRS was more pronounced among asthmatics than 
among non- asthmatics.
Although statistical power is reduced for higher level interac-
tions, we evaluated possible three- way interactions in situations 
where we identified significant two- way interactions. We found 
some evidence that the interaction between GRS and current 
smoking on reduced FEV1/FVC was stronger among asthmatics 
than non- asthmatics and among women than men. However, 
because of small numbers within these three- way cross- classified 
strata, interpretation of any significant three- way interactions 
requires caution.
For FEV1/FVC, we observed significant interaction between 
its GRS and smoking status; for FEV1 and FVC, we did not find 
interactions between their GRSs and smoking status. Results were 
similar for interactions between the GRSs and asthma status: 
present only for FEV1/FVC. FEV1/FVC is an index of airflow 
obstruction which is a characteristic of asthma and COPD and 
occurs with smoking.37 Significant interactions between GRS and 
smoking or asthma for only FEV1/FVC may reflect the fact that 
this parameter is independent of lung size. Genetic effects on 
FEV1 and FVC, which reflect lung size, may have a predominant 
impact through lung development, which takes place largely in 
early life, rather than later response to environmental exposures 
or diseases. We also note that Aschard et al,24 who examined 
both FEV1 and FEV1/FVC, identified an interaction between 
GRS and smoking predominantly for FEV1/FVC.
To our knowledge, our study is the first to examine interac-
tions between GRS of pulmonary function traits and asthma or 
house dust endotoxin exposure. Aschard et al found a significant 
interaction on FEV1/FVC between an unweighted GRS based 
on 26 loci and ever versus never smoking, although this finding 
did not replicate in two independent datasets.24 In the larger 
meta- analysis of Shrine et al, a single GRS based on 279 SNPs 
weighted by the effect sizes for FEV1/FVC was constructed. That 
GRS did not interact with smoking status dichotomised as ever 
versus never.8 We constructed a separate GRS based on the 278 
of the 279 SNPs present in our data and tested for its interac-
tion with smoking status (current, former vs never) in relation to 
FEV1/FVC. The interaction effects with smoking status were not 
significant (former smokers: pinteraction=0.11, current smokers: 
pinteraction=0.20). However, using the more standard approach of 
creating a GRS based on clumping plus p value thresholding, 
we observed a significant interaction between our 1691- SNP 
GRS and smoking status in relation to FEV1/FVC. This obser-
vation also highlights the advantage of using clumping plus p 
value thresholding to create a GRS over simple selection of top 
SNPs as discussed by Choi et al.38 Shrine et al did not divide 
ever smokers into former and current for the interactions with 
GRS in their study. After several years from quitting, the decline 
in pulmonary function in former smokers tends to level off, so 
Table 4 Interaction between smoking and GRS in relation to FEV1/FVC
Exposure n
FEV1/FVC
Intercept* Smoking effect† GRS effect‡
GRS×smoking interaction: difference 
in the effect of GRS per smoking 
category§ Pinteraction¶
Smoking
  Never 1884 0.760 – −0.003 – –
  Former 839 0.738 −0.022 −0.006 −0.003 0.064
  Current 121 0.673 −0.087 −0.012 −0.009 0.017
*The intercept at each smoking category is the FEV1/FVC value for a subject in that smoking category calculated at the mean value for all continuous variables in the model (GRS, age, age
2, height, height2 and 10 
principal components) and at the reference category for all categorical covariates (ie, non- asthmatic, female and residing at Iowa).
†The effect of smoking is obtained by subtracting the intercept value for never smoking from the intercept value for the smoking category in question. For example, for former smokers, 0.738–0.760=−0.022 is the 
difference in FEV1/FVC for a former smoker relative to a never smoker calculated at the mean value for all continuous variables (GRS, age, age
2, height, height2 and 10 principal components) and at the reference 
category for all categorical covariates (ie, non- asthmatic, female and residing at Iowa).
‡The effect for the GRS is the individual slope for that GRS for each exposure category and is interpretable as the difference in FEV1/FVC per unit increase in the GRS.
§The interaction effect between the GRS and smoking is the difference in the effect estimate for that GRS by smoking category and is calculated as the difference in the slope for the GRS for that smoking category 
relative to never smokers. For former smokers this difference is −0.006−(−0.003)=−0.003.
¶The p value for interaction between the GRS and each smoking category.
GRS, Genetic Risk Score.
Figure 1 Association between GRS and FEV1/FVC differs by smoking 
status. FEV1/FVC is regressed on smoking status, GRS and their 
interaction, adjusting for age, age2, height, height2, state, gender, 
asthma status and 10 principal components. Shown are the estimated 
FEV1/FVC values from the model against the range of GRS in our data 
for the three smoking categories (never, former and current), calculated 
at the mean values of all continuous variables (GRS, age, age2, height, 
height2 and 10 principal components) and at the reference category 
for all categorical covariates (ie, non- asthmatic, female and residing at 
Iowa). The shaded areas denote 95% pointwise confidence bands. GRS, 
Genetic Risk Score.
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it is important to consider ever smokers in more detail. In our 
study, rather than creating just one weighted GRS, we created 
a separate GRS for each pulmonary function trait weighted by 
the effect sizes for that trait. Our GRSs were based on the same 
large comprehensive GWAS meta- analysis as Shrine et al,8 and 
we found evidence of interaction with smoking considering 
former and current smokers separately. The interaction was 
most notable in our data for current smokers relative to never 
smokers.
Our study has some limitations. Because asthma was cate-
gorised based on questionnaires, misclassification with COPD 
is possible. We did not adjust for socioeconomic status (SES). 
Occupation is often used to adjust for SES. Our participants 
were enrolled in the parent cohort because they were either 
farmers or spouses of farmers. By sharing an occupation, they 
would be regarded as having similar SES. Nevertheless, when we 
considered education as an alternate proxy for SES, the results 
did not materially change. Consistent with other genetic studies 
of pulmonary function, we did not adjust for comorbidities. 
However, if insufficient adjustment for SES or comorbidities can 
bias estimates of interaction with the GRS, we cannot exclude 
the possibility that this occurred. Because this is an agricul-
tural population, participants potentially had higher exposure 
to endotoxin than the general US population. Additionally, all 
participants in this study and those in the UK Biobank and the 
SpiroMeta consortium were of European ancestry. Further, vari-
ants included in the GRS have different directions of associa-
tions with the pulmonary function traits. Although we recoded 
these directions to be uniform, combining the variants into a 
GRS might lose some information. However, assessing interac-
tions using GRS provides greater statistical power than using 
individual variants.
In most GWAS of pulmonary function, even though multiple 
correlated traits are examined simultaneously, correction for 
multiple testing based on the number of traits examined is not 
usually done.8 9 There are few GWASs focusing on interaction 
hypotheses. We used a nominal p value of 0.05 for reporting 
significant interactions. If one were to adjust interaction p values 
for the three traits and three exposures considered, the p value 
threshold would be 0.05/9=0.006. At this stricter correction, 
none of our interaction findings would be significant. Thus, 
caution is required in the interpretation of our results pending 
replication in future studies.
A strength of the study is that we developed a separate GRS 
for each pulmonary function trait using a meta- analysis involving 
around 400 000 participants of European ancestry,8 the largest 
GWAS of pulmonary function to date. This large- scale meta- 
analysis enabled generation of authoritative risk scores for 
pulmonary function in ALHS; we used these to investigate 
whether reduced pulmonary function associated with genetic 
risk is magnified in the presence of smoking or other exposures 
that have been related to reduced pulmonary function.
In conclusion, we developed separate GRSs for three pulmo-
nary function traits in our study of asthma nested within an agri-
cultural cohort. We identified significant interactions for FEV1/
FVC between its GRS and smoking status and marginally signif-
icant interactions for FEV1/FVC between its GRS and asthma. 
Our data support the use of GRS to identify environmental 
interactions with genetic susceptibility. Although small numbers 
induced by further stratification require caution, we saw some 
evidence that, for FEV1/FVC, the interaction between its GRS 
and smoking status differed by asthma and by gender. While it 
Table 5 Interaction between asthma and GRS in relation to FEV1/FVC
Exposure n
FEV1/FVC
Intercept* Asthma effect† GRS effect‡
GRS×asthma interaction: 
difference in the effect of GRS 
per asthma category§ Pinteraction¶
Asthma
  No 1803 0.751 – −0.003 – –
  Yes 1041 0.704 −0.047 −0.006 −0.003 0.053
*The intercept at each asthma category is the FEV1/FVC value for a subject in that asthma category calculated at the mean value for all continuous variables in the model (GRS, age, age
2, height, height2, pack- years and 
10 principal components) and at the reference category for all categorical covariates (ie, never smoker, female and residing at Iowa).
†The effect of asthma is obtained by subtracting the intercept value for non- asthmatics from the intercept value for the asthmatics; that is, 0.704–0.751=−0.047 is the difference in FEV1/FVC for an asthmatic relative to 
a non- asthmatic calculated at the mean value for all continuous variables (GRS, age, age2, height, height2, pack- years and 10 principal components) and at the reference category for all categorical covariates (ie, never 
smoker, female and residing at Iowa).
‡The effect for the GRS is the individual slope for GRS for each exposure category and is interpretable as the difference in FEV1/FVC per unit increase in the GRS.
§The interaction effect between the GRS and asthma is the difference in the effect estimate for the GRS by asthma category and is calculated as the difference in the slope for the GRS for asthmatics relative to non- 
asthmatics; that is, −0.006−(−0.003)=−0.003.
¶The p value for interaction between the GRS and asthma.
GRS, Genetic Risk Score.
Figure 2 Association between GRS and FEV1/FVC differs by asthma 
status. FEV1/FVC is regressed on asthma status, GRS and their 
interaction, adjusting for age, age2, height, height2, state, gender, 
smoking status, pack- years, and 10 principal components. Shown are 
the estimated FEV1/FVC values from the model against the range of 
GRS in our data for the two asthma categories, calculated at the mean 
values of all continuous variables (GRS, age, age2, height, height2, 
pack- years and 10 principal components) and 0 value for all categorical 
covariates (ie, never smoker, female and residing at Iowa). The shaded 
areas denote 95% pointwise confidence bands. GRS, Genetic Risk Score.
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has been difficult to identify appreciable evidence of gene by envi-
ronment interactions in genome- wide analyses at the individual 
SNP level, combining data across SNPs from large- scale GWAS 
through the use of GRSs can identify such interactions. Using 
the GRS approach, we find evidence that the impact of genetic 
susceptibility on reduced FEV1/FVC is enhanced in the presence 
of smoking or asthma. These findings provide evidence that the 
population with higher genetic risk for impaired pulmonary 
function is more susceptible to the deleterious effects of smoking 
and asthma. Our findings might hint at potential biological 
mechanisms underlying the interactions between genetic vari-
ants and exposure to smoking, or presence of asthma, in relation 
to lung function. For example, significant interactions between 
genetic risk for reduced pulmonary function and smoking might 
suggest that some SNPs related to pulmonary function operate 
by influencing pathways for response to smoking, even though 
previous analyses of interaction with the individual SNPs have 
not identified significant interactions. Studies incorporating 
additional types of omics data, including proteomics and metab-
olomics, might help shed light on possible mechanisms. Future 
studies assessing interaction between GRSs and factors related 
to reduced pulmonary function would help to support stronger 
inferences regarding potential relevance in clinical practice.
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